Metaproterenol
Class
Bronchodilators
Subclass
Short-acting beta-agonists
Substance name
Metaproterenol
Common formulations
Syrup
Dosage and administration
Adults patients
Reversible airway obstruction in patients with asthma
Reversible airway obstruction in patients with COPD
Indications for use
Labeled indications
Adults
Safety risks
Boxed warnings
Cardiac arrhythmias
Serotonin syndrome
Contraindications
A seizure disorder
Diabetes mellitus
Thyroid disease
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters
Breastfeeding
Acceptable for use during breastfeeding.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Uncommon < 1%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource